...
首页> 外文期刊>Serbian Journal of Experimental and Clinical Research >Anti-gbm Rapidly Progressive Glomerulonephritis (Syndroma Goodpasture): A Case Report
【24h】

Anti-gbm Rapidly Progressive Glomerulonephritis (Syndroma Goodpasture): A Case Report

机译:抗gbm快速进展性肾小球肾炎(综合症Goodpasture):病例报告

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Goodpasture syndrome is a severe illness caused by the formation of antibodies to the glomerular basement membrane and alveolus with consequential damage to renal and pulmonary function. With current therapy, long-term survival is more than 50%. Before, the mortality was higher than 90%. In our patient, the disease began as dysuria, continued as anaemic syndrome, and ended with the development of end-stage renal failure. Immunosuppressive therapy with pulse doses of methylprednisolone and cyclophosphamide has put the disease into remission, but the permanent impairment of renal function remained. Early diagnosis of Goodpasture syndrome helps preserve renal function and improves patients’ survival. In patients who achieve remission, a kidney transplant can be considered. Currently, our patient is awaiting transplantation.
机译:Goodpasture综合征是一种严重疾病,由肾小球基底膜和肺泡抗体的形成引起,从而损害了肾脏和肺功能。使用目前的疗法,长期生存率超过50%。以前,死亡率高于90%。在我们的患者中,该疾病始于排尿困难,持续至贫血综合征,并随着晚期肾衰竭的发展而结束。脉冲剂量的甲基强的松龙和环磷酰胺的免疫抑制治疗使疾病得以缓解,但肾功能永久受损。 Goodpasture综合征的早期诊断有助于保留肾功能并改善患者的生存率。在达到缓解的患者中,可以考虑进行肾脏移植。目前,我们的患者正在等待移植。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号